BACKGROUND
Chronic kidney disease (CKD) is increasingly recognized as a systemic disorder characterized by profound metabolic, inflammatory, and endocrine derangements. Among the endocrine abnormalities observed in CKD, hyperprolactinemia and hypothalamic-pituitary-gonadal axis dysfunction are highly prevalent yet freq...
Vincenzo Barbera, L. Di Lullo, Antonio Bellasi et al.· CardioRenal Medicine· 0 citations
The role of low-density lipoprotein cholesterol (LDL-C) in the excess cardiovascular risk associated with CKD is addressed and the impact of both traditional and novel LDL-C-lowering therapies across the entire spectrum of CKD is examined.
R. Minutolo, M. Ravera, M. Cozzolino et al.· Giornale Italiano di Nefrolo...· 0 citations
Chronic kidney disease (CKD) represents a clinically relevant setting in which Lp(a) levels may rise as renal function declines, contributing to the excess cardiovascular burden and residual risk left unaddressed by historical statin trials in the end-stage renal disease population.
L. Di Lullo, Paola Peverini, Antonio Bellasi et al.· CardioRenal Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.